Week of August 22, 2023 | Vol. 12, Issue 33

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline

Pharmaceutical Technology - Aug 14, 2023

Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to front of pharma's growth pack in Q2

Fierce Pharma - Aug 15, 2023

Frontage Labs Completes Nucro-Technics Acquisition

Contrat Pharma - Aug 16, 2023

Frontage Labs acquires Canadian CRO Nucro-Technics for undisclosed sum

Fierce Biotech - Aug 17, 2023

US Appeals court rules in favour of further abortion pill restrictions

Pharmaceutical Technology - Aug 17, 2023

Honeywell, Recipharm Partner on pMDIs with Near-zero GWP Propellant

Contract Pharma - Aug 17, 2023

Parexel picks pact with Partex to leverage AI for trials, drug development

Fierce Biotech - Aug 17, 2023

The Pharmacy-Benefit Sector Just Took a Hit

WSJ - Aug 18, 2023

Signal: Bruker continues acquisition spree with $108m PhenomeX purchase

Pharmaceutical Technology - Aug 21, 2023

Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities

FDA - Aug, 2023

TANNER NEWS

Managed access programs explained with TannerMAP

Tanner’s Managed Access Program (MAP) division specializes in increasing access to life-saving treatments for patients who would otherwise be unable to access them, either via pre-approval access programs or global donation programs. TannerMAP also develops and delivers access programs for specific medicines from manufacturer partners. Learn more.